Who founded Graviton Bioscience Corporation?

Graviton Bioscience Corporation was founded by Samuel Waksal in 2020.

Who are Graviton Bioscience Corporation's investors?

Graviton Bioscience Corporation's investors include Pontifax Venture Capital.

How much funding has Graviton Bioscience Corporation raised?

Graviton Bioscience Corporation has disclosed $93.3M raised across 4 rounds.

Where is Graviton Bioscience Corporation headquartered?

Graviton Bioscience Corporation is headquartered in New York, US.

Graviton Bioscience Corporation

New York, US · Founded 2020 · 1 known investors

Find your way into Graviton Bioscience Corporation

Biotech

Founders & leadership

Graviton Bioscience Corporation was founded in 2020 by Samuel Waksal.

Samuel WaksalFounder

Steven GordonExecutive

Board

Philip BarachBoard director

Richard GirouxBoard director

Investors · 1

Pontifax Venture CapitalHerzeliya · $6.3M – $128M

Reported raises · per SEC filings

Form D private placements

$93.3M disclosed across 4 rounds · 2021–2024

▶$25MraisedFeb 2024 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Samuel D WaksalExecutive Officer, Director, Promoter
Bihua ChenDirector
Jeremy LevinDirector
David MacMillanDirector
James BoylanDirector
Stelios PapadopoulosDirector
Ran NussbaumDirector

Offering amount: $25M
Amount sold: $25M
First sale: Jan 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$39.8MraisedDec 2023 · 11 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

James BoylanDirector
Bihua ChenDirector
Samuel D. WaksalExecutive Officer, Director
Jeremy LevinDirector
David MacMillanDirector
Stelios PapadopoulosDirector
Ran NussbaumDirector

Offering amount: $50M
Amount sold: $39.8M
First sale: Dec 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$25MraisedDec 2023 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jeremy LevinDirector
Ran NussbaumDirector
Samuel D. WaksalExecutive Officer, Director
Bihua ChenDirector
Stelios PapadopoulosDirector
James BoylanDirector
David MacMillanDirector

Offering amount: $25M
Amount sold: $25M
First sale: Nov 2023
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3.5MraisedFeb 2021 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Steven GordonExecutive Officer, Director
Richard GirouxDirector
Samuel WaksalDirector
Philip BarachDirector

Offering amount: $30M
Amount sold: $3.5M
First sale: Feb 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors - BioSpacebiospace.com · May 2023

Frequently asked questions

Who founded Graviton Bioscience Corporation?: Graviton Bioscience Corporation was founded by Samuel Waksal in 2020.
Who are Graviton Bioscience Corporation's investors?: Graviton Bioscience Corporation's investors include Pontifax Venture Capital.
How much funding has Graviton Bioscience Corporation raised?: Graviton Bioscience Corporation has disclosed $93.3M raised across 4 rounds.
Where is Graviton Bioscience Corporation headquartered?: Graviton Bioscience Corporation is headquartered in New York, US.